Form 4: AbbVie Executive Chairman Richard Gonzalez Sells 66,500 Shares

Richard Gonzalez, Executive Chairman of AbbVie, sold 66,500 shares of common stock at a weighted average price of $186.52 on August 5, 2024.

Summary

• On August 5, 2024, Richard Gonzalez, the Executive Chairman of AbbVie Inc., sold 66,500 shares of AbbVie's common stock.
• The sale was executed at a weighted average price of $186.52 per share.
• Following the transaction, Gonzalez directly owns 446,599 shares of AbbVie common stock.
• The shares were sold in multiple transactions with prices ranging from $186.50 to $186.90.
• This transaction was reported on a Form 4 filing with the Securities and Exchange Commission.

Sentiment

Score: 5

Explanation: The document itself is neutral, simply reporting a stock sale. The sentiment is neither particularly positive nor negative without additional context.

Industry Context

Executive stock sales are a common occurrence and are often scrutinized by investors for insights into management's perspective on the company's future prospects. However, these sales can be for various personal financial reasons and don't always indicate a negative outlook.

Comparison to Industry Standards

• Executive compensation and stock ownership are closely monitored in the pharmaceutical industry.
• Comparing Gonzalez's stock transactions and ownership to peers at companies like Johnson & Johnson (JNJ), Pfizer (PFE), and Merck (MRK) could provide context.
• Analyzing the frequency and size of insider transactions across these companies can reveal industry trends and benchmarks.

Stakeholder Impact

• Shareholders may react to the news of the stock sale, although the impact is likely to be minimal given the size of the transaction relative to the company's market capitalization.
• The sale does not directly impact employees, customers, suppliers, or creditors.

Key Dates